← Back to Patent Explorer
US4298609A Expired / Lapsed US ⏱️ 0.0 years remaining

4,5-Dihydro-6-(4-pyridinyl)-3-pyridazinol and salts, their preparation and use as blood pressure lowering agents

Assignee: Sanofi SA
•
Filing: 1979-08-30
•
Granted: 1981-11-03
•
Expires: 1999-08-30
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract 4,5-Dihydro-6-(4-pyridinyl)-3-pyridazinol or pharmaceutically-acceptable acid-addition salt thereof is useful as a blood pressure lowering agent. 4,5-Dihydro-6-(4-pyridinyl)-3-pyridazinol is prepared by reacting γ-oxo-γ-(4-pyridinyl)butyronitrile with a hydrazine salt of a strong inorganic or organic sulfonic acid. Said 4,5-dihydro-6-(4-pyridinyl)-3-pyridazinol or pharmaceutically-acceptable salt thereof is shown as the active ingredient in pharmaceutical compositions for lowering blood pressure and in the method for lowering blood pressure in a patient having elevated blood pressure.

Inventors

  • 👤 George Y. Lesher
  • 👤 William B. Dickinson

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-07 23:56
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/495; A61K31/50

Claims Analysis

Total Claims: 12
Claim 1
Independent Claim 42 words
The method for lowering blood pressure in a patient having elevated blood pressure which comprises administering orally or parenterally in a solid or liquid dosage form to such patient a blood pressure lowering effective amount of 4,5-dihydro-6-(4-pyridinyl)-3-pyridazinol or pharmaceutically-acceptable acid-addition salt thereof.
Claim 2
Independent Claim 42 words
The method for lowering blood pressure in a patient having elevated blood pressure which comprises administering orally or parenterally in a solid or liquid dosage form to such patient a blood pressure lowering effective amount of 4,5-dihydro-6-(4-pyridinyl)-3-pyridazinol or pharmaceutically-acceptable acid-addition salt thereof.
Claim 3
Dependent Claim 6 words
4,5-Dihydro-6-(4-pyridinyl)-3-pyridazinol or pharmaceutically-acceptable acid-addition salt thereof.
Claim 4
Dependent Claim 6 words
4,5-Dihydro-6-(4-pyridinyl)-3-pyridazinol or pharmaceutically-acceptable acid-addition salt thereof.
Claim 5
Dependent Claim 1 words
4,5-Dihydro-6-(4-pyridinyl)-3-pyridazinol.
Claim 6
Dependent Claim 1 words
4,5-Dihydro-6-(4-pyridinyl)-3-pyridazinol.
Claim 7
Dependent Claim 32 words
A pharmaceutical composition for lowering blood pressure, which comprises a pharmaceutically-acceptable inert carrier and, as the active component thereof, a blood pressure lowering effective amount of 4,5-dihydro-6-(4-pyridinyl)-3-pyridazinol or pharmaceutically-acceptable acid-addition salt thereof.
Claim 8
Dependent Claim 32 words
A pharmaceutical composition for lowering blood pressure, which comprises a pharmaceutically-acceptable inert carrier and, as the active component thereof, a blood pressure lowering effective amount of 4,5-dihydro-6-(4-pyridinyl)-3-pyridazinol or pharmaceutically-acceptable acid-addition salt thereof.
Claim 9
Dependent Claim 12 words
A composition according to claim 4 where the active component is 4,5-dihydro-6-(4-pyridinyl)-3-pyridazinol.
Claim 10
Dependent Claim 25 words
The process which comprises heating at about 65°-120° C. γ-oxo-γ-(4-pyridinyl)butyronitrile with a hydrazine salt of a strong inorganic or organic sulfonic acid to produce 4,5-dihydro-6-(4-pyridinyl)-3-pyridazinol.
Claim 11
Dependent Claim 25 words
The process which comprises heating at about 65°-120° C. γ-oxo-γ-(4-pyridinyl)butyronitrile with a hydrazine salt of a strong inorganic or organic sulfonic acid to produce 4,5-dihydro-6-(4-pyridinyl)-3-pyridazinol.
Claim 12
Dependent Claim 20 words
The process according to claim 6 where the reaction is run by refluxing γ-oxo-γ-(4-pyridinyl)butyronitrile with hydrazine sulfate in aqueous ethanol.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1984-11-02 1985-05-04 1985-11-03 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1988-11-02 1989-05-04 1989-11-03 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1992-11-02 1993-05-04 1993-11-03 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag